Abstract
A 6-month-old infant with a double outlet right ventricle, doubly committed ventricular septal defect, and right ventricle outflow tract (RVOT) stenosis underwent intracardiac repair with RVOT reconstruction using a fresh decellularized allograft derived from a 1-year-old heart transplant recipient in Japan. Early postoperative evaluation via echocardiography and cardiac magnetic resonance imaging revealed that the pulmonary allograft and cardiac function were stable. This is the first case report on using a decellularized heart valve, which was resected from a heart transplant recipient, for primary repair of congenital heart disease in Japan.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Neumann A, Sarikouch S, Breymann T, et al. Early systemic cellular immune response in children and young adults receiving decellularized fresh allograft for pulmonary valve replacement. Tissue Eng Part A. 2014;20:1003–11.
Iop L, Bonetti A, Naso F, et al. Decellularized allogeneic heart valves demonstrate self-regeneration potential after a long-term preclinical evaluation. PLoS One. 2014;18:e99593.
Sarikouch S, Horke A, Tudorache I, et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg. 2016;50:281–90.
Jashari R, Goffin Y, Vanderkelen A, et al. European homograft bank: 20 years of cardiovascular tissue banking and collaboration with transplant coordination in Europe. Transplant Proc. 2010;42:183–189.
Cebotari S, Tudorache I, Ciubotaru A, et al. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124:115–23.
Brockbank KG, Schenke-Layland K, Greene ED, et al. Ice-free cryopreservation of heart valve allografts: better extracellular matrix preservation in vivo and preclinical results. Cell Tissue Bank. 2012;13:663–71.
Acknowledgements
This work is supported by the Research on Decellularized Heart Valve for Clinical Application by the Japan Medical Association Center for Clinical Trials, and the Japan Agency for Medical Research and Development.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozawa, H., Ueno, T., Taira, M. et al. Application of decellularized allograft for primary repair of congenital heart disease in Japan. Gen Thorac Cardiovasc Surg 67, 976–978 (2019). https://doi.org/10.1007/s11748-018-0988-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-018-0988-9